Tag: CardioCel®
Admedus sells its CardioCel and VascuCel patch business for $A36.2m
ASX-listed health technologies manufacturer Admedus has reached an agreement to sell its CardioCel and VascuCel patch business to US based LeMaitre Vascular Inc. for up to...
Admedus completes acquisition of WA manufacturing site for CardioCel
Admedus has announced that it has completed the purchase of an established manufacturing site from Genzyme Australia to facilitate increased production of its lead...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
